The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets

Life science tool companies have traditionally operated in the “research use only” market—selling equipment and reagents to academic labs, research centers and biopharmaceutical R&D. By selling into the research-only market, these companies have been able to avoid the burdens of controls placed on regulated products. However, the line between research and clinical activities is increasingly … Continue reading “The Personalized Medicine Opportunity–Shifting the Business to Regulated Markets”